Details
- Organisation Name: Mackay Base Hospital
- HHS: Mackay
- Services Offered: Clinical trials site; Investigator Initiated Trials; Satellite Site; Trial Patient Recruitment; Treatment of patients; Completion of study documentation as per ICH GCP and contract
- Website Address: www.mackay.health.qld.gov.au/your-hospitals/mackay-base-hospital/
- Contact: Clinical Trials Unit – Mackay-Clinical-Trials@health.qld.gov.au
- Other Affiliated Research Sites: Royal Brisbane and Women's Hospital; Princess Alexandra Hospital; Rockhampton Hospital; Toowoomba Hospital; Townsville Hospital and Cairns Hospital.
Location
Is your Facility able to initiate study activities prior to Ethics Committee protocol approval?
No
How long before Ethics Committee review is the Submission Packet required?
2 weeks
Site Overview
Mackay Hospital and Health Service Clinical Trials Unit
The Mackay Hospital and Health Service (MHHS) Clinical Trials Unit (CTU) is dedicated to advancing medical research and providing early access to cutting-edge therapies for our patients and community. Our unit supports investigators involved in commercially sponsored, externally initiated, or collaborative clinical trials, ensuring that our patients benefit from the latest medical advancements.
Our Mission:
Early Access to Therapies: We aim to provide our patients with early access to innovative treatments and medical technologies through participation in clinical trials.
Advancing Medical Knowledge: By conducting clinical trials, we contribute to the advancement of scientific knowledge and the development of new standard-of-care treatments.
Rural and Remote Access: We offer teletrials in collaboration with the Queensland Regional Clinical Trials Coordinating Centre (QRCCC) other hospitals, such as Townsville University Hospital, to provide access to clinical trials for patients in rural and regional areas
The Mackay Hospital and Health Service (MHHS) Clinical Trials Unit (CTU) is dedicated to advancing medical research and providing early access to cutting-edge therapies for our patients and community. Our unit supports investigators involved in commercially sponsored, externally initiated, or collaborative clinical trials, ensuring that our patients benefit from the latest medical advancements.
Our Mission:
Early Access to Therapies: We aim to provide our patients with early access to innovative treatments and medical technologies through participation in clinical trials.
Advancing Medical Knowledge: By conducting clinical trials, we contribute to the advancement of scientific knowledge and the development of new standard-of-care treatments.
Rural and Remote Access: We offer teletrials in collaboration with the Queensland Regional Clinical Trials Coordinating Centre (QRCCC) other hospitals, such as Townsville University Hospital, to provide access to clinical trials for patients in rural and regional areas
HREC
- HREC Committee Name: Townsville HHS HREC
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Central Acting as Local
- Mandate distribution of safety: Yes
- Meeting frequency: Monthly
- Types of HREC (IRB/ERB/ETHICS) Committee that are used: Central Acting as Local
- Mandate distribution of safety: Yes
Facility staffing and training
- Handling Investigational Product: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: Yes
- Training program for the research staff: Yes
- Include GCP: Yes
- Facility written sop during transportation to satellite site: Yes
Licenses to receive, store, dispense and return controlled substances
- Required Licenses or Registrations: Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? Yes
- Does the Facility have the ability to handle radio-labelled Investigational Products? Yes
Equipment
- Investigational Product: Horizontal laminar flow hood (non-hazardous drug preparation)
- Centrifuge: Yes
- Refrigerated Centrifuge: No
- Centrifuge: Yes
- Refrigerated Centrifuge: No
Patient Records
- Record Archiving: Yes
- EMR/EHR systems: In-house
- Has your Clinical Trial Site or Service been accredited? N/A
- Audit Type: N/A
- EMR/EHR systems: In-house
- Has your Clinical Trial Site or Service been accredited? N/A
- Audit Type: N/A
Investigational product storage Capabilities
- Refrigerator (2 to 8 Degrees C): Yes
- Freezer (-20 to -30 Degrees C): No
- Investigational Freezer (-70 to -80 Degrees C): No
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
- Freezer (-20 to -30 Degrees C): No
- Investigational Freezer (-70 to -80 Degrees C): No
- Investigational Freezer (Liquid Nitrogen -135 Degrees C): No
- Does this equipment have back-up power? Yes
- Does this equipment provide Min/Max Temperature Monitoring? Yes
- Do you have the ability to generate a temperature monitoring log for this equipment? Yes
- Does this equipment have a temperature alarm? Yes
- Do you have an SOP which supports calibration of this equipment? Yes
Specialty Research Area
Acute Kidney Disease
Adult Coronary Syndrome
Anaemia
Angina
Aortic
Aplastic Anaemia
Arteriosclerosis
Atherosclerosis
Atrial Fibrillation
Atypical Haemolytic
Basal Cell Carcinoma
Benign Prostatic Hyperplasia
Bladder Cancer
Bone Cancer
Brain Cancer
Brain Ischemia
Breast Cancer
Cancer
Cardiovascular Diseases
Cervical Cancer
Chronic Heart Failure
Colorectal Cancer
Congestive Heart Failure
Coronary Artery Disease
Critical Care
Crohn's Disease
Cystitis
Dialysis
Digestive System Diseases
Diverticulitis
Endometriosis
Erectile Dysfunction
Febrile Neutropenia
Female Urogenital Diseases and Pregnancy Complications
Fertility
Follicular Lymphoma
Gastro Intestinal Solid Tumours
Gastro Oesophageal Refulx Disease (GERD)
Haemophilia
Head and Neck Cancer
Hepatocellular Carcinoma
Hereditary Angioedema
HR Prostate Cancer
Hypocalcaemia
Hypochlorhydria
Hypotension
Iron Deficiency Anaemia
Iron Overload
Ischemic Heart Disease
Islet Cell Tumours
Leukaemia
Leukopenia
Liver Cancer
Lung Cancer
Lymphoma
Malignant Pleural Mesothelioma
Melanoma
Mental Disorders
Mitral Valve Prolapse
Multiple Myeloma
NASH
Neoplasms
Neuroma
Non- Hodgkin's Lymphoma
Non-Small Cell Lung Cancer
NSCLC
Ovarian Epithelial Carcinoma
Overactive Bladder
Paediatrics
Pancreatic Cancer
Pancreatitis
Pericarditis
Peyronie's Disease
Phlebitis
Prostate Cancer
Refractory Anaemia
Renal Cell Carcinoma
Renal Failure
Sarcoma
Sickle Cell Anaemia
Soft Tissues Sarcomas
Solid tumours
Squamous & Non Squamous Sarcomas
Stroke
Throat Cancer
Thrombocytopenia
Thromboembolic Disease
Thyroid Cancer
Ulcerative Colitis
Upper GI Disorders
Uremic Syndrome
Urinary Tract Infection
Vascular Disease
Venous Thromboembolism
Wounds and Injuries
Study Types
Academic
Industry
Investigator
Source Document Types
Paper and Electronic
Average time to start study (in calendar days)
Greater than 120
How long prior to HREC meeting does the application need to be submitted?
2 weeks
Does the HREC committee require contract /budget approval prior to release final approval documents?
Yes
Does your Facility support in-patient admissions?
Yes
PK & PD specimens
Yes
Study Phase Capability
Phase III
Phase IV
Type of Diagnostic Equipment
CT Scan Computerized Tomography Scan
MRI Magnetic Resonance Imaging
X-Ray
Patient Population
Adults - Ages 18-64
Geriatrics 65 and onwards